Biosimilars: The naming puzzle

FDA Pleases No One With Final Guidance On Naming of Biologicals and Biosimilars.

FDA pleases no one with final guidance on biological and biosimilar naming.

Biosimilars

Are Biosimilars Identical to the Reference Products?

Are Biosimilars Identical to the Reference Products?

The Science Behind Biosimilars

An important challenge currently facing rheumatologists and rheumatology health professionals is to gain an understanding of the landscape surrounding biosimilar agents, including the scientific, clinical, economic, and prescribing issues related to their use. The US Food and Drug Administration (FDA) defines a biosimilar as a biologic product that is “highly similar to” an approved biologic pr...